acut
pancreat
character
zymogen
preactiv
sever
inflamm
caus
zymogen
activ
eventu
lead
multipl
organ
dysfunct
contribut
high
mortal
rate
sever
acut
pancreat
howev
specif
treatment
avail
acut
pancreat
therapi
show
effect
inhibit
autophagi
flux
amelior
pathogenesi
acut
pancreat
induc
cerulein
larginin
camkii
phosphoryl
due
cytosol
calcium
overload
reveal
paper
also
demonstr
autophag
protein
aggreg
degrad
blockad
accompani
impair
autophagi
correl
posit
intraacinar
cell
digest
aymogen
activ
stimul
cerulein
larginin
role
amelior
acut
pancreat
shown
associ
impair
autophagi
inhibit
ca
overload
allevi
provid
promis
therapi
acut
pancreat
target
impair
autophagi
increas
cytosol
calcium
digest
zymogen
normal
work
secret
preactiv
pancreat
acinar
cell
selfdigest
result
caus
pancrea
injuri
directli
howev
mechan
underli
activ
digest
enzym
especi
trypsinogen
poorli
understood
autophagi
process
respons
longliv
protein
organel
degrad
autophagosom
engulf
cargo
fuse
lysosom
form
autolysosom
degrad
take
place
vesicl
accumul
area
necrot
pancreatit
tissu
first
identifi
autophagosom
electron
microscopi
reveal
defici
prevent
intracellular
trypsinogen
activ
acinar
cell
suggest
autophagi
posit
regul
promot
activ
digest
zymogen
pancreat
acinar
cell
consist
autophagi
flux
inhibitor
wortmannin
report
protect
trypsinogen
activ
induc
major
caus
lead
acut
pancreat
incid
acut
pancreat
increas
howev
specif
treatment
avail
acut
pancreat
therapi
time
although
mechan
acut
pancreat
fulli
elucid
believ
earli
event
process
acut
pancreat
includ
vacuol
accumul
calcium
overload
cytokin
activ
earli
stage
acut
pancreat
introduct
acut
pancreat
kind
selflimit
diseas
patient
acut
pancreat
recov
howev
may
develop
sever
acut
pancreat
mortal
rate
sever
acut
pancreat
due
complic
lung
renal
dysfunct
among
divers
etiolog
alcohol
abus
follow
duct
obstruct
bacteri
infect
induc
gallston
amelior
acut
pancreat
via
inhibit
impair
autophagi
allevi
calcium
overload
guidelin
care
use
laboratori
anim
eighth
edit
approv
ethic
committe
anim
experi
youjiang
medic
univers
nation
studi
mice
model
acut
pancreat
includ
ceruleinand
larginineinduc
model
construct
previous
describ
ceruleininduc
model
four
intraperiton
inject
cerulein
bodi
weight
given
consecut
hourli
interv
larginineinduc
model
receiv
hourli
intraperiton
inject
gkg
optim
dosag
studi
larginin
three
time
rat
randomli
divid
six
group
n
per
group
first
three
group
design
ceruleininduc
model
analysi
group
control
group
cerulein
ceruleininduc
pancreat
without
treatment
group
cerulein
ceruleininduc
pancreat
treatment
mgkg
given
intraperiton
inject
min
first
cerulein
inject
next
group
relat
larginineinduc
model
analysi
group
control
group
larginin
larginineinduc
pancreat
without
treatment
group
larginin
larginineinduc
pancreat
treatment
mgkg
given
intraperiton
inject
min
first
larginin
inject
observ
chang
inflamm
process
mice
randomli
select
kill
serum
amylas
analysi
three
six
nine
hour
last
inject
cerulein
larginin
mice
sacrif
nine
hour
last
inject
cerulein
larginin
analysi
serum
amylas
lipas
western
blot
histopatholog
chang
serum
level
amylas
lipas
determin
use
commerci
assay
kit
accord
manufactur
instruct
indic
cytosol
calcium
phosphoryl
camkii
regul
acut
pancreat
induc
cerulein
larginin
calcium
overload
phosphoryl
camkii
could
revers
follow
commerci
antibodi
use
rabbit
sigma
rabbit
ptg
rabbit
antiubiquitin
ptg
rabbit
antitubulin
ptg
rabbit
sab
rabbit
ptg
rabbit
santa
cruz
biotechnolog
rabbit
sab
rabbit
signalway
antibodi
sab
igg
secondari
antibodi
ptg
follow
chemic
reagent
also
use
cerulein
yeasen
baptaam
aat
bioquest
yeasen
larginin
chloriquiton
cq
sigma
hydrochlorid
bgam
sigma
amylas
lipas
elisa
kit
sigma
elisa
kit
r
system
obtain
laboratori
jun
ying
yuan
shanghai
pancreat
cell
line
american
tissu
cultur
collect
cultur
dulbecco
modifi
eagl
medium
hyclon
contain
fetal
bovin
serum
hyclon
penicillinstreptomycin
hyclon
atmospher
co
use
standard
techniqu
studi
carri
use
femal
kunm
km
mice
switzerland
mice
fourweeksold
weigh
obtain
shanghai
slac
laboratori
anim
co
mice
hous
microisol
plastic
cage
suppli
basal
diet
autoclav
distil
water
ad
libitum
anim
care
experiment
procedur
compli
cerulein
amelior
pathogenesi
acut
pancreat
extent
howev
wortmannin
effect
inhibit
autophagi
autophagysom
increment
result
trypsinogen
preactiv
seen
case
increas
autophagi
flux
autophagi
blockag
recent
illustr
autophagysom
accumul
due
autophagi
blockag
probabl
key
factor
zymogen
activ
model
acut
pancreat
induc
alcohol
togeth
lipopolysaccharid
lp
found
fusion
ratio
autophagysom
lysosom
decreas
due
local
lysosomeassoci
membran
protein
defici
inflam
pancreat
tissu
almost
time
demonstr
autophagi
flux
inhibit
led
imbal
cathepsin
b
cathepsin
c
eventu
stimul
trypsinogen
activ
ceruleininduc
acut
pancreat
result
support
theori
autophagi
flux
actual
block
process
acut
pancreat
concept
impair
autophagi
pathogenesi
acut
pancreat
thu
establish
specif
potent
autophagi
welldocu
highli
effect
autophagi
inhibitor
shown
valuabl
therapeut
virus
inhibit
autophagi
flux
hypothes
decreas
amount
autophagysom
could
protect
intraacinar
cell
digest
zymogen
activ
test
hypothesi
model
acut
pancreat
induc
cerulein
larg
dose
larginin
result
indic
amelior
ceruleinor
larginineinduc
acut
pancreat
mechan
act
acut
pancreat
reveal
associ
impair
autophagi
inhibit
calcium
overload
anoth
characterist
acut
pancreat
rapidli
activ
pancreat
ca
calmodulindepend
protein
kinas
ii
camkii
cholecystokinin
cck
treatment
g
igg
secondari
antibodi
two
hour
room
temperatur
studi
antibodi
act
intern
control
result
band
visual
electrochemiluminesc
ecl
system
amersham
bioscienc
studi
ubiquitin
ub
level
protein
aggreg
elucid
abovement
western
blot
briefli
triton
insolubl
fraction
cultur
cell
mice
pancreat
tissu
dissolv
sd
separ
analyz
immunoblot
antiubiquitin
antibodi
student
test
oneway
anova
use
analyz
signific
differ
group
error
bar
microscopi
present
standard
deviat
triplic
sampl
error
bar
western
blot
analysi
repres
standard
deviat
densitometri
data
three
uniqu
experi
statist
analys
done
use
statist
packag
social
scienc
spss
version
spss
institut
supplementari
materi
avail
onlin
wwwmolmedorg
previou
report
shown
anim
model
acut
pancreat
produc
cerulein
larg
dose
larginin
autophagi
impair
damag
promot
trypsinogen
activ
thu
question
whether
ceruleinor
larginineinduc
autophagi
damag
aros
vitro
treat
acinar
cell
cerulein
figur
presenc
absenc
chloriquiton
cq
block
cytosol
calcium
analysi
cell
load
calcium
indic
calcium
visual
fluoresc
microscopi
imag
cellular
calcium
fluoresc
intens
qualifi
imag
j
soft
version
nation
institut
health
unit
state
america
protein
extract
cultur
cell
mice
pancreat
tissu
separ
quantifi
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
transfer
polyvinyliden
fluorid
pvdf
membran
millipor
block
nonfat
milk
phosphat
buffer
salin
pb
membran
immunoblot
indic
primari
antibodi
includ
antiubiqutin
anticamkii
antiphoscamkii
bodi
horseradish
peroxidaseconjug
immunoglobulin
pancreat
tissu
obtain
mice
fix
overnight
neutralbuff
formalin
routin
paraffin
embed
cut
four
mm
hematoxylin
eosin
h
e
stain
histolog
analysi
studi
histopatholog
chang
includ
edema
necrosi
infiltr
inflamm
cell
vacuol
qualifi
accord
criteria
describ
tabl
final
score
calcul
sum
abovement
four
paramet
section
evalu
two
independ
pathologist
unawar
studi
target
lysat
cell
mix
bgam
trypsin
reaction
buffer
mmmolltri
mmoll
cacl
ph
min
incub
fluoresc
intens
measur
nm
excit
nm
data
suggest
protect
trypsinogen
activ
intraacinar
cell
may
partli
ascrib
function
inhibit
impair
autophagi
elucid
therapeut
potenti
acut
pancreat
construct
mice
model
acut
pancreat
use
cerulein
larginin
explor
therapeut
role
acut
pancreat
model
ceruleininduc
acut
pancreat
model
observ
pretreat
significantli
diminish
elev
serum
amylas
lipas
level
indic
trypsin
activ
figur
left
middl
given
pancrea
injuri
trypsinogen
preactiv
usual
accompani
inflamm
reaction
next
detect
effect
inflamm
indic
tumor
necrosi
factor
subunit
figur
right
interestingli
increas
level
serum
caus
cerulein
inhibit
presenc
figur
right
although
express
littl
chang
pancrea
tissu
mice
acut
pancreat
activ
form
downregul
figur
histopatholog
analys
show
treatment
amelior
inflamm
damag
induc
cerulein
edema
degener
coagul
necrosi
infiltr
inflammatori
cell
tabl
repres
graph
exhibit
kind
damag
figur
sinc
found
decreas
impair
autophagi
vitro
detect
level
beclin
protein
vivo
result
show
increas
level
protein
pancreat
tissu
acut
inflamm
decreas
condit
treatment
figur
correspondingli
elev
ubiquityl
protein
aggreg
insolubl
fraction
diminish
level
ubiquitin
solubl
fraction
increas
figur
suggest
autophagi
flux
inhibit
induc
cerulein
larginin
might
correl
trypsinogen
activ
vitro
taken
togeth
conclud
autophagi
flux
blockad
also
refer
impair
autophagi
pancreat
acinar
cell
upon
cerulein
larginin
treatment
studi
support
theori
impair
autophagi
import
trypsinogen
activ
process
acut
pancreat
potenti
therapeut
effect
antiviru
infect
cancer
therapi
due
high
effici
autophagi
flux
inhibit
hypothes
could
protect
trypsinogen
activ
prove
determin
whether
trypsin
activ
induc
cerulein
larginin
acinar
cell
decreas
condit
treatment
figur
b
result
show
inhibit
trypsinogen
activ
induc
cerulein
figur
larginin
figur
determin
relationship
inhibit
trypsinogen
activ
impair
autophagi
intraacinar
cell
detect
protein
level
ubiquityl
protein
aggreg
use
western
blot
figur
result
show
level
decreas
cell
cerulein
treatment
compar
cerulein
without
treatment
figur
moreov
downregul
occur
timedepend
manner
figur
note
level
ubiquityl
protein
aggreg
decreas
insolubl
fraction
increas
solubl
ubiquitin
treatment
consist
function
promot
ubiquitin
figur
similar
result
also
obtain
cell
case
larginin
treatment
figur
f
fusion
autophagosom
lysosom
result
show
level
microtubuleassoci
protein
light
chain
form
ii
marker
autophagi
increas
cell
treat
cerulein
cq
figur
howev
increment
level
condit
treatment
cerulein
cq
figur
suggest
autophagi
could
block
pancreat
acinar
cell
cerulein
treatment
similar
result
obtain
largininetr
pancreat
acinar
cell
figur
elucid
role
autophagi
pancreat
acinar
cell
cerulein
larginin
treatment
next
detect
protein
level
also
known
sqstm
import
scaffold
protein
involv
ubiquitin
degrad
protein
aggreg
autolysosom
consist
increas
level
level
gradual
elev
time
dose
cerulein
treatment
figur
supplementari
figur
larginin
treatment
figur
supplementari
figur
sinc
ubiquityl
protein
aggreg
transport
autophagysom
degrad
also
investig
effect
cerulein
larginin
ubiquitin
protein
aggreg
result
western
blot
reveal
ubiquitin
protein
aggreg
upregul
significantli
insolubl
fraction
solubl
ubiquitin
remain
almost
constant
figur
supplementari
figur
compar
ubiquityl
protein
aggreg
level
express
autophagi
flux
posit
regul
slightli
increas
figur
supplementari
figur
confirm
relationship
impair
autophagi
pathogenesi
acut
pancreat
perform
vitro
reaction
catalyz
trypsin
pancreat
acinar
cell
found
trypsin
activ
acinar
cell
gradual
increas
increas
level
figur
f
supplementari
figur
summari
result
trypsin
activ
next
analyz
fluoresc
intens
data
three
independ
experi
test
student
test
shown
mean
sd
cf
cell
indic
treatment
lyse
analyz
western
blot
ub
antitubulin
antibodi
rel
level
express
quantifi
use
imag
j
exhibit
bar
graph
three
independ
set
experi
c
e
line
graph
two
independ
set
experi
f
error
bar
repres
sd
student
test
use
p
p
p
ceruleininduc
mice
model
acut
pancreat
inject
half
hour
first
inject
cerulein
mice
sacrif
nine
hour
last
cerulein
inject
analyz
serum
amylas
lipas
level
histopatholog
chang
c
level
b
ub
pancreat
tissu
data
serum
analys
test
use
oneway
anova
lsd
correct
shown
mean
sd
eh
larginineinduc
mice
model
acut
pancreat
inject
min
first
inject
larginin
mice
sacrif
nine
hour
last
larginin
inject
analyz
serum
amylas
lipas
level
e
histopatholog
chang
g
level
f
ub
h
pancreat
tissu
data
serum
analys
test
use
oneway
anova
lsd
correct
shown
mean
sd
ratio
level
rel
protein
tubulin
list
band
meanwhil
still
exist
evid
suggest
autophagi
promot
pancreat
acinar
cell
surviv
autophagi
respons
engulf
zymogen
refer
zymophagi
inhibit
lead
acinar
cell
death
besid
trypsin
activ
found
mice
recent
taken
togeth
two
seemingli
controversi
evid
suggest
hypothesi
put
forward
damag
pancreat
tissu
induc
autophagi
elimin
protein
organel
injuri
benefit
cell
surviv
begin
damag
supra
extent
system
stand
impair
autophagi
occur
caus
activ
trypsinogen
previou
research
fulli
knock
thu
autophagi
still
exist
mice
case
damag
still
could
elimin
earli
stage
pancreat
lower
level
impair
autophagi
induc
later
stage
result
decreas
level
trypsinogen
activ
howev
autophagi
larg
inhibit
mice
high
defici
result
damag
accumul
begin
induc
trypsinogen
activ
thu
whether
autophagi
benefici
depend
phase
acut
pancreat
earli
stage
hypothesi
still
explor
cytosol
calcium
recent
report
impact
level
impair
autophagi
liver
injuri
induc
high
fat
diet
hfd
case
autophosphoryl
camkii
indic
elev
level
cytosol
calcium
hepatocyt
induc
correspondingli
calcium
channel
blocker
verapamil
could
allevi
liver
injuri
thu
reason
amelior
pathogenesi
acut
pancreat
partli
due
allevi
calcium
overload
cytosol
calcium
elev
lead
impair
autophagi
accumul
case
liver
injuri
caus
hfd
report
effect
protect
trypsinogen
activ
induc
cerulein
larginin
vitro
vivo
amelior
acut
pancreat
like
mediat
via
decreas
level
impair
autophagi
allevi
cytosol
calcium
overload
autophag
vesicl
accumul
import
event
earli
process
acut
pancreat
indic
autophagi
locat
inner
membran
autolysosom
autophagi
flux
elev
lead
increas
product
autophagi
blockad
lead
decreas
fuse
lysosom
upregul
level
result
indic
increas
level
pancreat
acinar
cell
upon
cerulein
larginin
treatment
mainli
due
inhibit
autophagi
flux
anoth
evid
impair
autophagi
pancreat
chang
autophagi
flux
posit
regul
minor
need
mention
share
similar
trend
cerulein
larginin
treatment
easili
understand
fluctuat
actual
autophagi
indic
case
upregul
autophagi
block
henc
share
similar
trend
function
autophagi
independ
also
reveal
thu
unknown
event
may
exist
cerulein
larginin
treatment
protein
aggreg
reveal
correl
trypsin
activ
ubiquityl
protein
aggreg
degrad
autophagi
may
directli
trigger
activ
trypsinogen
possibl
caus
cellular
toxic
shown
promot
transform
ubiquityl
protein
aggreg
solubl
form
accompani
trypsin
activ
thu
protein
aggreg
accumul
result
autophagi
blockad
might
import
target
amelior
acut
pancreat
induc
cerulein
larginin
similar
result
observ
mice
model
acut
pancreat
use
larginin
tabl
figur
h
taken
togeth
data
suggest
therapeut
potenti
acut
pancreat
possibl
inhibit
impair
autophagi
calcium
overload
wellknown
characterist
acut
pancreat
detect
cytosol
calcium
use
calcium
sensit
dye
found
cytosol
calcium
elev
ceruleinor
largininetr
cell
vitro
figur
b
calcium
overload
result
trypsinogen
preactiv
acut
pancreat
calcium
chelat
baptaam
use
conform
relationship
calcium
elev
trypsinogen
activ
present
studi
correspondingli
trypsinogen
activ
acinar
cell
allevi
condit
baptaam
figur
given
cytosol
calcium
may
affect
autophagi
question
whether
play
role
calcium
signal
pathway
answer
first
evalu
fluoresc
intens
pancreat
acinar
cell
without
treatment
found
significantli
diminish
cytosol
calcium
load
caus
cerulein
larginin
figur
f
next
analyz
chang
camkii
includ
phosphoryl
form
pancreat
acinar
cell
treat
cerulein
larginin
result
show
phosphoryl
camkii
gradual
increas
time
dose
cerulein
larginin
treatment
level
camkii
chang
slightli
figur
h
supplementari
figur
interestingli
increas
phosphoryl
level
induc
cerulein
larginin
would
decreas
condit
treatment
figur
j
togeth
data
support
amelior
pathogenesi
acut
pancreat
might
correl
reliev
calcium
overload
camkii
could
consid
marker
increas
calcium
level
pancreat
acinar
cell
pancreat
may
partli
due
calcium
overload
similar
indic
role
calcium
hepatocyt
phosphoryl
could
revers
verapamil
thu
impair
autophagi
exist
ceruleinor
larginineinduc
acut
fluoresc
imag
analyz
imag
j
graph
provid
quantifi
use
imag
j
mean
sd
three
independ
set
experi
student
test
use
c
cell
treat
normal
salin
nmoll
cerulein
c
mmoll
larginin
h
presenc
absenc
baptaam
addit
three
hour
trypsin
activ
next
analyz
fluoresc
intens
data
three
independ
experi
test
student
test
shown
mean
sd
e
f
cell
treat
nmoll
cerulein
e
mmoll
larginin
f
h
presenc
absenc
cell
stain
accord
manufactur
instruct
fluoresc
imag
analyz
imag
j
graph
provid
quantifi
use
imag
j
mean
sd
three
independ
set
experi
student
test
use
lysat
cell
g
h
mice
pancrea
j
indic
treatment
analyz
western
blot
anticamkii
antiphoscamkii
antitubulin
antibodi
